(6) The AG prevented the endothelial dysfunction (VE-cadherin and PECAM) and the upregulation of mesenchymal transition markers (vimentin, fascin1, and Hsp47) observed by IRI. The gene discussed is SERPINH1; the disease is endothelial dysfunction.